Cumberland Pharmaceuticals, Inc. (CPIX)
3.89
+0.05
(+1.30%)
USD |
NASDAQ |
Feb 24, 16:00
3.89
0.00 (0.00%)
After-Hours: 19:59
Cumberland Pharmaceuticals EPS Diluted (Quarterly) : -0.1297 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ImmuCell Corp. | -0.0154 |
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.949M |
| Revenue (Quarterly) | 8.292M |
| Total Expenses (Quarterly) | 10.23M |
| Enterprise Value | 52.16M |
| Gross Profit Margin (Quarterly) | 75.56% |
| Profit Margin (Quarterly) | -23.50% |
| Earnings Yield | -5.99% |
| Normalized Earnings Yield | -5.537 |